About PRIMMUNE THERAPEUTICS, INC.
Primmune is a clinical-stage biotechnology company focused on developing systemic cancer immunotherapies that activate the immune system in a precise and controlled manner. The company is advancing therapies designed to strengthen antitumor immunity and improve long-term disease control.
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| ORAL BROAD SPECTRUM ANTIVIRAL TLR7 AGONIST FOR TREATMENT OF LASSA FEVER | Department of Defense | $11.0M |
Is this your company?
Claim PRIMMUNE THERAPEUTICS, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim PRIMMUNE THERAPEUTICS, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.